Scatter plot of C9 immunoblots revealed a significant increase of C9 level in non-metastatic CRC patients (p-value = 0.0002, Figure 6A) and metastatic CRC patients (p-value = 0.0007) compared to those in the healthy controls. This evidence concerns the gene C9 and colorectal carcinoma.